Common GLP-1 side effects may include mild nausea or digestive discomfort, which usually subside as your body adjusts
Research shows anxiety might go up at first, but long-term use can make mood better
NICEs 2024 technology appraisal on tirzepatide says the clinical evidence suggests tirzepatide is more effective overall for managing overweight and obesity than semaglutide and diet-and-exercise support alone
Since different laboratories utilise a wide range of synthesis methods, including template-based calcination, hydrothermal and solvothermal reactions, resulting CQDs often display inconsistencies in size, charge, and fluorescence behaviour [167]
Global Data, Assessing the Economic Impact of Obesity and Overweight on Employers, Feb 2024
Expiry date: Indicated on the packaging